ETF Exchange > BBP ETF
BBP - ETF Fact Sheet
Virtus LifeSci Biotech Products ETF - USD
Fund Identification
Ticker
BBP
ISIN
US26923G2021
Main Metrics
Price
$97.55Expense Ratio
0.34%AuM
$97.55MTracking Difference
-1.60%Ratings
Trackinsight rating
N/AOfficial Investment Strategy
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index, which tracks the performance of biotechnology companies with at least one drug therapy approved by the FDA.
BBP's historical prices, performance, and flows
1m returns
11%
1m flows
$10M
* Net total returns
All data as of 17 July 2026
The ETF Exchange is brought to you by
With data and analysis by
See all BBP data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
BBP's characteristics
Manager
Manager statistics
24 funds, $2.87Bn in AUM
Benchmark
LifeSci Biotechnology Products Total Return Index - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
BBP's exposure
Countries
USA
92.13%
United Kingdom
7.83%
Sectors
Healthcare
100.00%
Top 5 holdings
Immunocore Holdings Plc
7.64%
Rhythm Pharmaceuticals, Inc.
7.57%
ACADIA Pharmaceuticals, Inc.
7.49%
Sarepta Therapeutics, Inc.
7.41%
Phathom Pharmaceuticals, Inc.
7.29%
Total holdings
58
Total weight of top 5
37.40%
